Mesenchymal stem cells expressing TNF-alpha receptor

Details for Australian Patent Application No. 2012216549 (hide)

Owner Osiris Therapeutics, Inc.

Inventors Tyrell, Alicia; Danilkovitch, Alla; Bubnic, Simon; Marcelino, Michelle; Monroy, Rodney; Carter, Diane

Agent Spruson & Ferguson

Pub. Number AU-A-2012216549

Parent 2011202952

Filing date 30 August 2012

Wipo publication date 20 September 2012

International Classifications

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/0775 Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal stem cells

Event Publications

13 September 2012 Complete Application Filed

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216549

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216550-Cloud assisted rendering

2012216548-Container with cover